Sign in
CompletedNo phase

A Case Report of NMDAR Encephalopathy

Key facts

Who runs it
Mayo Clinic
Where
Jacksonville, United StatesSee the site
Trial code
Status
Completed
People taking part
1 person enrolled
Started
20 Jun 2024
Ended
19 Dec 2024
Type of study
Observational
Treatments tested
  • Magnetic Resonance Imaging (MRI)
  • Salpingo-oophorectomy
Record updated
8 April 2025

Who can take part

Age
34 years to 34 years
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Suspected Anti-NMDA Encephalitis

Who cannot take part

  • Inability to consent

Where in United States

  • Mayo Clinic in FloridaJacksonville, United States

About the trial

What the trial wants to find out

This case illustrates the clinical, radiologic, and histopathologic features of Anti-NMDAR encephalitis and underscores the importance of MRI in detecting ovarian teratomas when pelvic ultrasound is inconclusive.

Treatments tested

  • Magnetic Resonance Imaging (MRI)
  • Salpingo-oophorectomy

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
8 April 2025